WFS1 and hearing loss disorder: Through an agnostic genome‐wide association study (GWAS), a single nucleotide polymorphism (SNP) in WFS1 (rs62283056; p = 1.4 × 10−8) was associated with increased susceptibility to cisplatin‐induced hearing loss,11 and replicated in an independent Canadian study of 229 TCS evaluating the same phenotype (p = 5.67 × 10−3).14